Evidence map›Paper›PMID 38343452›Full record

ArticleProceedings (Baylor University. Medical Center)2024

Low-dose methotrexate toxicity leading to pancytopenia: leucovorin as a rescue treatment.

George Schelzel, Anirudh Palicherla, Abubakar Tauseef, Paul Millner

Open access · greenAbstract readCase Reports
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. A Case series of Acute Methotrexate Toxicity.Annals of African medicine · 2026
    Article
  2. Article
  3. Methotrexate Toxicity Management in Polymyalgia Rheumatica: A Case Report.Journal of community hospital internal medicine perspectives · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

George SchelzelDepartment of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.ORCID https://orcid.org/0000-0003-2681-4101
Anirudh PalicherlaDepartment of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.
Abubakar TauseefDepartment of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.
Paul MillnerDepartment of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA.
Creighton University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-dose methotrexate has several known side effects associated with mild toxicity including nausea, oral ulcers, and anemia. However, it is rare for patients taking low-dose methotrexate to present with symptoms of severe toxicity including pancytopenia, macular punctate rash, and severe stomatitis. Here we present an 83-year-old patient with a history of rheumatoid arthritis on low-dose methotrexate for 1 year presenting with 5 days of worsening facial swelling, oral lesions, and a macular rash to the extremities. Initial workup revealed severe leukopenia, thrombocytopenia, and previously undiagnosed chronic kidney injury. Computed tomography showed edema surrounding a left maxillary dental implant suggestive of infection. The patient was admitted for suspected methotrexate toxicity complicated by possible dental infection. Methotrexate was withheld. The patient's stomatitis and facial swelling improved with administration of folate, leucovorin, and piperacillin/tazobactam. The patient's severe neutropenia gradually resolved following administration of granulocyte colony-stimulating factor. Infectious workup was negative throughout admission. This case report details factors that precipitate severe methotrexate toxicity at low doses.

Indexed as

Leucovorinmethotrexatepancytopeniarheumatoid arthritistoxicity

Identifiers

PMID38343452
PMCPMC10857683
OpenAlexW4389743228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.